diabetes
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.without diabetes mellitus 2.20 years of age or older 3.before the study, able to understand our explanation on the study and obtain the written informed consent based on their own free will
Exclusion criteria
Exclusion criteria: 1.the use of medications that affect glucose metabolism (such as corticosteroids, beta-blockers) 2.existing or possible pregnancy 3.brestfeeding 4.an investigator's declaration that the participant was otherwise inappropriate for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between the parameters of glycemic variability calculated from the continuous glucose monitoring data and the index of beta cell function calculated from the data of hyperglycemic clamp and euglycemic hyperinsulinemic clamp | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Association between the parameters of glycemic variability calculated from the continous glucose monitoring data and the index of beta cell function calculated from the date of 75g oral glucose tolerance test (75g OGTT) 2.Association between the indices of beta cell function calculated from the data of 75g OGTT and glucose clamp 3.Association between anthropometric data, serum lipid profile, basal metabolic rate measured with indirect calorimeter and the parameters of glycemic variability or the indices of beta cell function | — |
Countries
Japan
Contacts
Kobe University Graduate School of Medicine Division of Diabetes and Endocrinology